Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan G C van Hasselt

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Pharmaceutics|April 28, 2023
Evaluation of a Cardiovascular Systems Model for Design and Analysis of Hemodynamic Safety StudiesYu Fu, Nelleke Snelder, Tingjie Guo, et al.
British Journal of Pharmacology|June 3, 2018
Quantitative systems pharmacology analysis of drug combination and scaling to humans: the interaction between noradrenaline and vasopressin in vasoconstrictionAnyue Yin, Akihiro Yamada, Wiro B Stam, et al.
Pharmaceutical Research|December 15, 2010
Systematic evaluation of the descriptive and predictive performance of paediatric morphine population modelsElke H J Krekels, Johan G C van Hasselt, Dick Tibboel, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 29, 2019
A Review of Mathematical Models for Tumor Dynamics and Treatment Resistance Evolution of Solid TumorsAnyue Yin, Dirk Jan A R Moes, Johan G C van Hasselt, et al.
Scientific Reports|March 11, 2022
Anti-cancer treatment schedule optimization based on tumor dynamics modelling incorporating evolving resistanceAnyue Yin, Johan G C van Hasselt, Henk-Jan Guchelaar, et al.
Frontiers in Physiology|September 28, 2017
Mechanistic Systems Modeling to Improve Understanding and Prediction of Cardiotoxicity Caused by Targeted Cancer TherapeuticsJaehee V Shim, Bryan Chun, Johan G C van Hasselt, et al.
Antimicrobial Agents and Chemotherapy|April 14, 2010
Population pharmacokinetics of vancomycin in premature Malaysian neonates: identification of predictors for dosing determinationYoke-Lin Lo, Johan G C van Hasselt, Siow-Chin Heng, et al.
British Journal of Clinical Pharmacology|December 11, 2012
Optimizing drug development of anti-cancer drugs in children using modelling and simulationJohan G C van Hasselt, Natasha K A van Eijkelenburg, Jos H Beijnen, et al.
European Journal of Clinical Pharmacology|June 5, 2012
Population pharmacokinetics of lamotrigine in Indian epileptic patientsSurulivelrajan Mallaysamy, Martin G Johnson, Padma G M Rao, et al.
British Journal of Clinical Pharmacology|August 3, 2022
Modelling inflammatory biomarker dynamics in a human lipopolysaccharide (LPS) challenge study using delay differential equationsFeiyan Liu, Linda B S Aulin, Tingjie Guo, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Pharmaceutics|April 28, 2023
Evaluation of a Cardiovascular Systems Model for Design and Analysis of Hemodynamic Safety StudiesYu Fu, Nelleke Snelder, Tingjie Guo, et al.
British Journal of Pharmacology|June 3, 2018
Quantitative systems pharmacology analysis of drug combination and scaling to humans: the interaction between noradrenaline and vasopressin in vasoconstrictionAnyue Yin, Akihiro Yamada, Wiro B Stam, et al.
Pharmaceutical Research|December 15, 2010
Systematic evaluation of the descriptive and predictive performance of paediatric morphine population modelsElke H J Krekels, Johan G C van Hasselt, Dick Tibboel, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 29, 2019
A Review of Mathematical Models for Tumor Dynamics and Treatment Resistance Evolution of Solid TumorsAnyue Yin, Dirk Jan A R Moes, Johan G C van Hasselt, et al.
Scientific Reports|March 11, 2022
Anti-cancer treatment schedule optimization based on tumor dynamics modelling incorporating evolving resistanceAnyue Yin, Johan G C van Hasselt, Henk-Jan Guchelaar, et al.
Frontiers in Physiology|September 28, 2017
Mechanistic Systems Modeling to Improve Understanding and Prediction of Cardiotoxicity Caused by Targeted Cancer TherapeuticsJaehee V Shim, Bryan Chun, Johan G C van Hasselt, et al.
Antimicrobial Agents and Chemotherapy|April 14, 2010
Population pharmacokinetics of vancomycin in premature Malaysian neonates: identification of predictors for dosing determinationYoke-Lin Lo, Johan G C van Hasselt, Siow-Chin Heng, et al.
British Journal of Clinical Pharmacology|December 11, 2012
Optimizing drug development of anti-cancer drugs in children using modelling and simulationJohan G C van Hasselt, Natasha K A van Eijkelenburg, Jos H Beijnen, et al.
European Journal of Clinical Pharmacology|June 5, 2012
Population pharmacokinetics of lamotrigine in Indian epileptic patientsSurulivelrajan Mallaysamy, Martin G Johnson, Padma G M Rao, et al.
British Journal of Clinical Pharmacology|August 3, 2022
Modelling inflammatory biomarker dynamics in a human lipopolysaccharide (LPS) challenge study using delay differential equationsFeiyan Liu, Linda B S Aulin, Tingjie Guo, et al.
Pageof 4